OFA Group receives 180-day extension to cure minimum bid price deficiency
OFA Group received notice from Nasdaq on June 9, 2026, granting a second 180-calendar-day compliance period through December 7, 2026, to regain compliance with the minimum $1.00 bid price per share requirement. The company, which fell below the $1.00 minimum for 30 consecutive business days and was previously given until June 9, 2026, to cure the deficiency, remains eligible for the extended period because it meets all other Nasdaq continued listing requirements. The company stated it intends to monitor bid prices and evaluate options, including a potential reverse stock split, to regain compliance.
Key facts
- Second compliance period extended through December 7, 2026
- Company must maintain closing bid price of at least $1.00 per share for minimum of 10 consecutive business days to regain compliance
- Initial compliance date of June 9, 2026 passed without cure
- Company meets all other Nasdaq continued listing standards except minimum bid price requirement
- Company indicated intention to effect reverse stock split, if necessary, to cure deficiency
- Original deficiency notice received December 11, 2025
Why it matters
OFA Group has secured additional time to avoid delisting, but faces a December 7, 2026 deadline to raise its share price above $1.00 or implement a reverse stock split; failure to cure by that date will trigger a delisting determination subject to potential appeal.
Share
Get the next chapter in your inbox — a Sentinel watches this company and briefs the next material filing the moment it lands.
Derived from 8-K filed 2026-06-12. Not investment advice. View the source filing on SEC.gov →